Literature DB >> 2449079

Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.

B Patsner1, W J Mann, H Cohen, M Loesch.   

Abstract

Serum CA 125 levels were measured preoperatively by standard radioimmunometric techniques in 89 patients with primary endometrial carcinoma before definitive surgical staging and resection. Fifty-seven of 58 (98%) patients with clinical and surgical Stage I or II disease had normal preoperative serum CA 125 levels. All eight patients with clinically advanced endometrial cancer (International Federation of Gynecology and Obstetrics Stage III or IV) had elevated CA 125 levels before surgery. Twenty of 23 patients (87%) with clinical Stage I or II endometrial cancer who were found to have extrauterine spread of disease during staging laparotomy had elevated preoperative serum CA 125 levels. Thus preoperative CA 125 levels were elevated in 28 of 31 patients (90.3%) with surgically staged endometrial adenocarcinoma with extrauterine disease and may play a useful role in detecting those patients with clinically localized endometrial cancer who have occult extrauterine spread of disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449079     DOI: 10.1016/0002-9378(88)90163-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.

Authors:  Gloria S Huang; Lydia G Chiu; Juliana S Gebb; Marc J Gunter; Paniti Sukumvanich; Gary L Goldberg; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

2.  Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.

Authors:  H Hareyama; N Sakuragi; S Makinoda; S Fujimoto
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

3.  CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.

Authors:  G Crombach; A Scharl; H Würz
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

4.  Serum carcinoembryonic antigen as a tumour marker in patients with endometrial cancer.

Authors:  Y Hashiguchi; M Kasai; T Fukuda; T Ichimura; T Yasui; T Sumi
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

5.  Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.

Authors:  Zoya Yurkovetsky; Shlomo Ta'asan; Steve Skates; Alex Rand; Aleksey Lomakin; Faina Linkov; Adele Marrangoni; Lyudmila Velikokhatnaya; Matthew Winans; Elieser Gorelik; G Larry Maxwell; Karen Lu; Anna Lokshin
Journal:  Gynecol Oncol       Date:  2007-07-19       Impact factor: 5.482

6.  Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.

Authors:  Yasunori Hashiguchi; Mari Kasai; Takeshi Fukuda; Tomoyuki Ichimura; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Pathol Oncol Res       Date:  2015-12-17       Impact factor: 3.201

7.  Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery.

Authors:  Seung-Chul Yoo; Jong-Hyuck Yoon; Woo Young Kim; Suk-Joon Chang; Hee-Jae Joo; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

8.  Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.

Authors:  N Povolotskaya; N Das; K Dhar; D Brinkmann; F Gardner; R Woolas
Journal:  Surg Res Pract       Date:  2014-02-27

9.  Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer.

Authors:  Josef Chovanec; Iveta Selingerova; Kristina Greplova; Sofie Leisby Antonsen; Monika Nalezinska; Claus Høgdall; Estrid Høgdall; Erik Søgaard-Andersen; Kirsten M Jochumsen; Pavel Fabian; Dalibor Valik; Lenka Zdrazilova-Dubska
Journal:  Oncotarget       Date:  2017-11-21

Review 10.  Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012.

Authors:  Bruce Patsner; Ga Won Yim
Journal:  Obstet Gynecol Sci       Date:  2013-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.